wi 26va4 human fibroblast cell line Search Results


wi 26 va4  (ATCC)
95
ATCC wi 26 va4
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Wi 26 Va4, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wi+26va4+human+fibroblast+cell+line/pmc05133372-42-17-23?v=ATCC
Average 95 stars, based on 1 article reviews
wi 26 va4 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
human cell line wi 26va4  (ATCC)
99
ATCC human cell line wi 26va4
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Human Cell Line Wi 26va4, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wi+26va4+human+fibroblast+cell+line/pmc10145024-56-7-11?v=ATCC
Average 99 stars, based on 1 article reviews
human cell line wi 26va4 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
wi-26 va4 cells  (JCRB Cell Bank)
90
JCRB Cell Bank wi-26 va4 cells
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Wi 26 Va4 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wi+26va4+human+fibroblast+cell+line/10__1165_slash_rcmb__2019___0245oc-245-0-11?v=JCRB+Cell+Bank
Average 90 stars, based on 1 article reviews
wi-26 va4 cells - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
wi-26 va4 (human normal lung cell fibroblasts)  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures wi-26 va4 (human normal lung cell fibroblasts)
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Wi 26 Va4 (Human Normal Lung Cell Fibroblasts), supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wi+26va4+human+fibroblast+cell+line/pm31870813-101-58-67?v=European+Collection+of+Authenticated+Cell+Cultures
Average 90 stars, based on 1 article reviews
wi-26 va4 (human normal lung cell fibroblasts) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
wi-26, va4  (AcceGen Biotechnology)
N/A
SV40 transformedTumorigenecity: Isoenzyme: G6PD, BHistopathology: SV40 transformedSubculture: Split ratio: Media change: Reverse transcritase: Production.
   Buy from Supplier

Image Search Results


TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 VA4 cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.

Journal: Experimental & Molecular Medicine

Article Title: TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial–mesenchymal transition

doi: 10.1038/emm.2016.125

Figure Lengend Snippet: TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 VA4 cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.

Article Snippet: The human NSCLC cell lines, NCI-H292 and NCI-H838, and the human normal lung cell lines, MRC5 and WI-26 VA4, were acquired from the American Type Culture Collection (ATCC, Manassas, VA, USA), authenticated and maintained in early passages, no more than 6 months after receipt from ATCC.

Techniques: Binding Assay, Knockdown, Small Interfering RNA, Expressing, Quantitative RT-PCR, Western Blot, Control